QUANTDETECT

Based on technologies and know-how developed at Iwate Medical University Institute for Biomedical Sciences, Quantdetect, Inc. was launched on April 1, 2021, with the intention of "implementing the research product". Quantdetect provides assays that have been developed from our original technologies, leading to a safer and fulfilling future... Quantdetect has designed and developed technologies to identify and quantify such recurrent mutations among cancer patients. These technologies, called OTS-Probes and OTS-Assay, have made it possible to track the amount of tumor in the body just by drawing blood... We designed and developed OTS-Probes and OTS-Assay to provide optimal cancer treatment information.

Also known as: Quantdetect, Inc.

Primary location: Tokyo Japan